Last reviewed · How we verify
vehicle placebo nasal spray
A vehicle placebo nasal spray contains no active pharmaceutical ingredient and serves as an inert control formulation for clinical trials.
A vehicle placebo nasal spray contains no active pharmaceutical ingredient and serves as an inert control formulation for clinical trials. Used for Clinical trial control/comparator (not a therapeutic product).
At a glance
| Generic name | vehicle placebo nasal spray |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Vehicle placebos are used in clinical research as control comparators to isolate the true pharmacological effects of an active drug from placebo effects and natural disease progression. This particular formulation is a nasal spray vehicle—likely containing saline, buffering agents, and preservatives—without any therapeutic agent, allowing researchers to measure the efficacy of the actual drug being tested.
Approved indications
- Clinical trial control/comparator (not a therapeutic product)
Common side effects
Key clinical trials
- A Phase I Study Evaluating the Safety, Tolerability, and Pharmacokinetics of VVN432 Nasal Spray (PHASE1)
- A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis (PHASE3)
- A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis (PHASE2)
- Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy (PHASE2)
- Safety and Acceptability of Q GRFT Nasal Spray for COVID-19 Prophylaxis (PHASE1)
- Azelastine Allergen Chamber - Onset of Action Study (PHASE2)
- Alleviation of Common Cold Symptoms (PHASE1)
- Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- vehicle placebo nasal spray CI brief — competitive landscape report
- vehicle placebo nasal spray updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI